FDA Approves New Treatment for Diabetic Eye Condition Written by Ginger Vieira on May 28, 2019 The drug Eyela can be used to treat the early stages of diabetic retinopathy, reducing the chances of serious vision loss. Diabetic retinopathy is the leading cause of blindness in adults across the globe, according to the American Journal […]
FDA Approves New Treatment for Diabetic Eye Condition Read More »
THURSDAY, Aug. 4, 2016 (HealthDay News) When Diabetes Strikes, Get Moving to Lower Risk to Eyes; Study finds association between inactivity and heightened odds for diabetic retinopathyPeople with diabetes who remain inactive may have higher odds for a vision-robbing eye condition, new research suggests.While the study couldn’t prove a cause-and-effect relationship, researchers say a “couch
When Diabetes Strikes.. Read More »
Health Day NewsThe U.S. Food and Drug Administration on March, 2015Â approved the use of Eylea, an injected drug, to treat diabetic retinopathy in patients with diabetic macular edema.According to the U.S. Centers for Disease Control and Prevention, diabetic retinopathy is a leading cause of blindness in American adults. A third of those over 40 with
New FDA Drug for Diabetes Eye Condition Read More »
